e-learning
resources
Berlin 2008
Sunday, 05.10.2008
Vascular and interstitial remodelling in chronic lung disease: therapeutic interventions on the horizon
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
A role for PAR1 in lipopolysaccharide induced acute lung injury
P. Mercer, C. Scotton, J. Moffatt, C. Derian, R. Chambers (London, United Kingdom; Spring House, PA, United States Of America)
Source:
Annual Congress 2008 - Vascular and interstitial remodelling in chronic lung disease: therapeutic interventions on the horizon
Session:
Vascular and interstitial remodelling in chronic lung disease: therapeutic interventions on the horizon
Session type:
Oral Presentation
Number:
1324
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Mercer, C. Scotton, J. Moffatt, C. Derian, R. Chambers (London, United Kingdom; Spring House, PA, United States Of America). A role for PAR1 in lipopolysaccharide induced acute lung injury. Eur Respir J 2008; 32: Suppl. 52, 1324
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
The role of osteopontin in the pulmonary fibrosis caused by acute lung injury induced by lipopolysaccharide in rats
Source: Annual Congress 2011 - Acute respiratory failure
Year: 2011
The effect of heat co-treatment on acute lung injury of the rat induced by intratracheal lipopolysaccharide
Source: Eur Respir J 2002; 20: Suppl. 38, 488s
Year: 2002
Effects of autophagy on LPS-induced lung inflammation and acute lung injury (ALI) in vitro and in vivo
Source: International Congress 2018 – Role of microbial exposure and inflammation in lung injury
Year: 2018
The effect of N-acetylcysteine in the acute lung injury rat model stimulated by LPS endotoxin
Source: Annual Congress 2009 - Mechanisms of pulmonary inflammation and fibrosis
Year: 2009
The effect of dexamethasone on the pulmonary fibrosis of acute lung injury induced by lipopolysaccharide in rats
Source: Annual Congress 2007 - Respiratory pathophysiology
Year: 2007
Effect of lipopolysaccharide (LPS) priming on
Candida
-induced acute lung injury (ALI)
Source: Eur Respir J 2003; 22: Suppl. 45, 585s
Year: 2003
CD101 eosinophil serves as an early response to suppress endotoxin-induced acute lung injury
Source: International Congress 2018 – Role of microbial exposure and inflammation in lung injury
Year: 2018
Effects of anti-IL17 on acute lung injury induced by LPS in mice
Source: International Congress 2017 – Anti-inflammatory and pro-repair mediators in acute lung injury
Year: 2017
PTX3 as a component of innate immunity in the role of captopril in acute lung injury induced by bacterial endotoxin
Source: Annual Congress 2011 - Anti-inflammatory strategies in acute lung injury
Year: 2011
Effect of curcumin on LPS-induced neutrophil activation and acute lung injury
Source: Annual Congress 2012 - Lung injury, respiratory muscles and mechanical ventilation
Year: 2012
The sensory irritant receptor TRPA1 is essential for airway inflammation in the LPS mouse model of acute lung injury.
Source: International Congress 2019 – Advances in asthma pharmacology
Year: 2019
Hsp90 binding inhibitors improve survival in a murine model of sepsis induced acute lung injury
Source: Annual Congress 2006 - Novel pathogenic aspects of acute lung injury and acute respiratory distress syndrome (ARDS)
Year: 2006
The role of leptin in pulmonary neutrophilia during murine acute lung injury
Source: Annual Congress 2011 - Lung cell injury and repair
Year: 2011
Anethole improves lipopolysaccharide (LPS)-induced lung injury
Source: Annual Congress 2009 - Experimental approaches in animals and modelling in humans
Year: 2009
Pioglitazone attenuates endotoxin-induced acute lung injury by reducing neutrophil recruitment
Source: Eur Respir J 2012; 40: 416-423
Year: 2012
Ghrelin attenuates lipopolysaccharide-induced acute lung injury
Source: Eur Respir J 2005; 26: Suppl. 49, 731s
Year: 2005
Enhanced expression of Robo4 ameliorates LPS-induced acute lung injury in mice
Source: Annual Congress 2011 - Acute respiratory failure
Year: 2011
Kallistatin protects against LPS-induced mouse lung injury
Source: Annual Congress 2012 - The many roads to lung injury
Year: 2012
Effect of protein S on lipopolysaccharide-induced acute lung injury
Source: Eur Respir J 2006; 28: Suppl. 50, 398s
Year: 2006
Role of syndecan-4 in acute lung inflammation
Source: Annual Congress 2010 - Novel markers of lung injury
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept